U.S. COMPANY FILING
PFIZER INC — Form 10-Q filed 2025-11-04
Filing text preview
Pfizer's Q3 2025 revenues were $16.65B, down 5.9% YoY; net income was $3.54B, down 20.7%. Nine-month revenues were $45.02B, down 1.8%; net income was $9.42B, up 23.6%. The company recorded a $1.35B IPR&D charge for the 3SBio licensing deal and continued cost realignment. Effective tax rate turned negative due to jurisdictional mix and tax resolutions.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record